IL-20 induced M2 macrophage differentiation from bone marrow-derived macrophages in vitro, and IL-20 blockade reduced CD206+ (marker for M2) macrophages in a pancreatic cancer model in vivo [222]. Here, IL20 is linked to familial pancreatic carcinoma.